BACE
An aspartic protease target associated with Alzheimer's disease, commonly used as a benchmark task for molecular property prediction and interpretability evaluation.
Timeline (last 90 days)
Using integrated gradients attribution, the fragment model achieves a hit rate of 1.5 times the random level in recovering known pharmacophores on the BACE target.
When aggregating the attribution results of the atom-level model, the BACE hit rate fluctuates with two arbitrary aggregation choices, sometimes higher and sometimes lower than the fragment model.
All Facts (2)
Using integrated gradients attribution, the fragment model achieves a hit rate of 1.5 times the random level in recovering known pharmacophores on the BACE target.
50%UnverifiedWhen aggregating the attribution results of the atom-level model, the BACE hit rate fluctuates with two arbitrary aggregation choices, sometimes higher and sometimes lower than the fragment model.
50%